New research shows sensitive corporate data is increasingly flowing through unsanctioned GenAI apps as workers bypass ...
We read with interest the Article by Marc P Bonaca and colleagues, which showed that the GLP-1 receptor agonist semaglutide improves walking distance by 13% in patients with peripheral artery disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results